WFH: Back to the future

Haemophilia, Supplement

Volumn 10, Issue 4, 2004, Pages 1-8

  O'Mahony, Brian ^a  

^a WORLD FEDERATION OF HEMOPHILIA   (Canada)

Author keywords

Development; Haemophilia; WFH

Indexed keywords

ARTICLE; DEVELOPING COUNTRY; HEALTH PROGRAM; HEMOPHILIA; INFORMATION PROCESSING; NON PROFIT ORGANIZATION; PRIORITY JOURNAL; PUBLICATION; QUALITY OF LIFE;

EID: 11044234586     PISSN: 13550691     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2516.2004.00981.x     Document Type: Article

References (30)

1. World Federation of Hemophilia. Annual Report 1994. Montreal: WFH.
2. World Federation of Hemophilia. Annual Report 2003. Montreal: WFH.
3. Hemophilia in Pictures. Montreal: WFH, 1998.
4. Kitchen S, McCraw A. Diagnosis of Hemophilia and Other Bleeding Disorders. A Laboratory Manual. Montreal: WFH, 2000.
5. Rodriguez Merchan EC, Goddard NJ, Lee CA. Musculoskeletal Aspects of Haemophilia. Oxford: Blackwell Science, 2000.
6. Farrugia A. Guide for the Assessment of Clotting Factor Concentrates for the Treatment of Hemophilia. Montreal: WFH, 2003.
7. World Federation of Hemophilia. Economic Benefits of Basic Hemophilia Treatment and Care. WFH Fact Sheet. Montreal: WFH, 2004.
8. World Federation of Hemophilia. Benefits of Treating Hemophilia with Factor Concentrate. WFH Fact Sheet. Montreal: WFH, 2004.
9. World Federation of Hemophilia. Economic Benefits of Comprehensive Hemophilia Care. WFH Fact Sheet. Montreal: WFH, 2004.
10. World Federation of Hemophilia. International Hemophilia Training Centre Directory. Montreal: WFH, 2003.
11. World Federation of Hemophilia. Improving Care Beyond our Borders. A Twinning Guide for Hemophilia Treatment Centres. Montreal: WFH, 2002.
12. World Federation of Hemophilia. Reaching Beyond our Borders. A Twinning Guide for Hemophilia Organizations. Montreal: WFH, 2001.
13. Schnabel M, Etzler J, eds. Status and Atlas of Hemophilia Worldwide. Munich, Germany: WFH Information Clearinghouse, 1984.
14. World Federation of Hemophilia. Report on the Annual Global Survey 2003. Montreal: WFH, 2004.
15. Evatt BL, Robillard L. Establishing haemophilia care in developing countries: using data to overcome the barrier of pessimism. Haemophilia 2000; 6: 131-4.
16. Giangrande PLF, Mariani G, Black C. The WFH Hemophilia Centre Twinning Programme: 10 years of growth, 1993-2003. Haemophilia 2003; 9: 240-4.
17. World Federation of Hemophilia. WFH Product Donation Procedures, Humanitarian Aid Program, February, 2003. Montreal: WFH.
18. O'Mahony B. Global Hemophilia Care-Challenges and Opportunities. Plenary Lecture, XXV International Congress of the WFH, Seville, Spain, May, 2002.
19. O'Mahony B. Hemophilia Societies: Challenges and Development. WFH Hemophilia Organization Development Monograph, no. 1. Montreal: WFH, 2000.
20. Clarke Gordon. Action Planning. WFH Hemophilia Organization Development Monograph, no. 2. Montreal: WFH, 2001.
21. Hashim Aris. Recruiting and Retaining Volunteers. WFH Hemophilia Organization Development Monograph, no. 3, Montreal: WFH, 2003.
22. World Federation of Hemophilia. Proceedings of the Global Forum on the Safety and Supply of Hemophilia Treatment Products, Montreal, April, 2000. Montreal: WFH.
23. World Federation of Hemophilia. Forum 2002 on the Safety and Supply of Hemophilia Treatment Products. Montreal January, 2002. Montreal: WFH.
24. World Federation of Hemophilia. Third Global Forum on the Safety and Supply of Hemophilia Treatment Products, Budapest Hungary, September, 2003. Montreal: WFH.
25. WFH TSE Task Force. WFH Statement on Transmission of vCJD by Transfusion. Montreal: WFH, 2003.
26. O'Mahony B. Global consultation mechanism on safety and supply issues. President's message. Hemophilia World, 2004.
27. Rankin Peter. Perilous economics of the industry. The Source 2003; September: 5-10.
28. Globe D, Cunningham W, Andersen R et al. The Hemophilia Utilization Study Group. Cost of out patient, in patient and pharmaceutical care. Int J Pediatric Hematol Oncol 2000; 7: 87-100.
29. Chandy M et al. Submission to the WHO Expert Committee on the Selection and Use of Essential Medicines. Montreal: WFH, 2004.
30. Lloyd S. The Preparation of Single Donor Cryoprecipitate WFH Monograph, Facts and Figures Series. Montreal: WFH, 1997.